316 related articles for article (PubMed ID: 19262544)
1. Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected].
Heidelbaugh JJ; Goldberg KL; Inadomi JM
Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S27-32. PubMed ID: 19262544
[TBL] [Abstract][Full Text] [Related]
2. Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences.
Barletta JF; Sclar DA
Pharmacoeconomics; 2014 Jan; 32(1):5-13. PubMed ID: 24271943
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Histamine
Hammond DA; Kathe N; Shah A; Martin BC
Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
[TBL] [Abstract][Full Text] [Related]
4. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center.
McCaleb RV; Gandhi AS; Clark SM; Clemmons AB
Ann Pharmacother; 2016 Jul; 50(7):541-7. PubMed ID: 27091869
[TBL] [Abstract][Full Text] [Related]
5. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
[TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.
Gyawali CP
Curr Gastroenterol Rep; 2017 Sep; 19(9):46. PubMed ID: 28780717
[TBL] [Abstract][Full Text] [Related]
7. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
8. A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.
Yu LY; Sun LN; Zhang XH; Li YQ; Yu L; Yuan ZQ; Meng L; Zhang HW; Wang YQ
Adv Ther; 2017 May; 34(5):1070-1086. PubMed ID: 28429247
[TBL] [Abstract][Full Text] [Related]
9. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
10. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
[TBL] [Abstract][Full Text] [Related]
11. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
[TBL] [Abstract][Full Text] [Related]
12. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
[TBL] [Abstract][Full Text] [Related]
13. [Gastroesophageal reflux disease: pathogenetic basis of differentiated tactics of treatment].
Tkachenko EI; Uspenskiĭ IuP; Karateev AE; Bakulin IG; Pakhomova IG
Eksp Klin Gastroenterol; 2009; (2):104-14. PubMed ID: 19552028
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitors: the good, the bad, and the unwanted.
Chubineh S; Birk J
South Med J; 2012 Nov; 105(11):613-8. PubMed ID: 23128806
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
Harris RA; Kuppermann M; Richter JE
Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
[TBL] [Abstract][Full Text] [Related]
16. Pneumonia prevention in intubated patients given sucralfate versus proton-pump inhibitors and/or histamine II receptor blockers.
Grindlinger GA; Cairo SB; Duperre CB
J Surg Res; 2016 Dec; 206(2):398-404. PubMed ID: 27884335
[TBL] [Abstract][Full Text] [Related]
17. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
[TBL] [Abstract][Full Text] [Related]
18. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
Targownik LE; Fisher DA; Saini SD
Gastroenterology; 2022 Apr; 162(4):1334-1342. PubMed ID: 35183361
[TBL] [Abstract][Full Text] [Related]
19. Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients.
Glew CM; Rentler RJ
J Am Med Dir Assoc; 2007 Nov; 8(9):607-9. PubMed ID: 17998118
[TBL] [Abstract][Full Text] [Related]
20. Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy.
Hershcovici T; Fass R
Drugs; 2011 Dec; 71(18):2381-9. PubMed ID: 22117130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
